Seven months ago CIC Health didnât exist. Today itâs running the stateâs mass vaccination effort
Innovation, speed, good connections helped it to quickly ramp up at Gillette Stadium
By Anissa Gardizy Globe Correspondent,Updated January 24, 2021, 3:56 p.m.
Email to a Friend
Tim Rowe started getting nervous last February.
The founder and chief executive of the Cambridge Innovation Center, a co-working company, had heard from CICâs Tokyo office about the emergence of a novel coronavirus.
Soon, the 20-year-old company had to shut down offices in various cities, along with much of the rest of the business world. Like many other companies at the time, CIC began placing large orders for personal protective equipment while brainstorming how it would socially distance clients in a space that was designed to bring them together. (Co-working offices allow individuals and companies to work in shared space spaces.)
Even with a vaccine, widespread COVID-19 testing is still crucial, experts say
By Laura Krantz Globe Staff,Updated December 18, 2020, 8:53 a.m.
Email to a Friend
As collective hope climbs
and doses of the long-awaited COVID-19 vaccine fan
out across the United States, many are eager to look past the painful nasal swabs, long lines, and slow turnaround times that mark the countryâs flawed testing system.
It wonât be that easy.
The onset of a vaccine only strengthens the need for a robust and responsive COVID-19 testing system, experts say, and we will need more testing than ever in the coming months because the virus is still raging and the vaccineâs effectiveness remains unclear.